Regulations.gov document
Ref 4 Murshid Mohaidin 2017 RE Agency Information Collection Activities; Submission for…
Supporting & Related Material · FDA-2020-N-1261 · posted Jun 16, 2021
Key facts
| Document ID | FDA-2020-N-1261-0006 |
|---|---|
| Title | Ref 4 Murshid Mohaidin 2017 RE Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Study of Disclosures to Healthcare Providers Regarding Data That Do Not Support Unapproved Use of an Approved Prescription Drug |
| Document type | Supporting & Related Material |
| Subtype | Background Material |
| Agency | FDA |
| Docket | FDA-2020-N-1261 |
| Posted | Jun 16, 2021 |
At a glance
- 1–9 Public comments on this docket
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Regulations.gov documents
Regulations.gov holds the rulemaking and other documents federal agencies post for public comment. Only agency documents are published here; public submissions are not.
Source: Regulations.gov (U.S. General Services Administration eRulemaking Program) · Source date: